Evidence map›Paper›PMID 29553327›Full record

ArticleEmerging infectious diseases2018

mcr-1 in Carbapenemase-Producing Klebsiella pneumoniae with Hospitalized Patients, Portugal, 2016-2017.

Ana Constança Mendes, Ângela Novais, Joana Campos, Carla Rodrigues, Cláudia Santos, Patrícia Antunes, Helena Ramos, Luísa Peixe

Abstract readHistorical Article
In one paragraph

Article in Emerging infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Molecular epidemiology of Klebsiella pneumoniae causing bloodstream infections in a district hospital in Northern Portugal (2016-2018): clonal diversity and detection of hypervirulent strains.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  4. Article
  5. Emerging carbapenem-resistantMicrobiology spectrum · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. A Comprehensive Genomic Analysis of the EmergentPathogens (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. AFrontiers in cellular and infection microbiology · 2022
    Article
  17. Article
  18. Article
  19. High prevalence ofJAC-antimicrobial resistance · 2021
    Article
  20. Characterization of aFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Constança Mendes
Ângela Novais
Joana Campos
Carla Rodrigues
Cláudia Santos
Patrícia Antunes
Helena Ramos
Luísa Peixe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a hospital-based outbreak caused by multidrug-resistant, Klebsiella pneumoniae carbapenemase 3-producing, mcr-1-positive K. pneumoniae sequence type 45 in Portugal. mcr-1 was located in an IncX4 plasmid. Our data highlight the urgent need for systematic surveillance of mcr-1 to support adequate therapeutic choices in the nosocomial setting.

Indexed as

HospitalizationAgedAged, 80 and overAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesDrug Resistance, Multiple, BacterialFemaleHistory, 21st CenturyHumansKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsMiddle AgedMultilocus Sequence TypingAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemaseantimicrobial resistancebacteriacarbapenemcolonizationIncX4Klebsiella pneumoniaemcrmcr-1multidrug resistancenosocomial infectionoutbreakplasmid-mediated colistin resistancePortugalST45

Identifiers

PMID29553327
PMCPMC5875258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.